NEW STUDY SUBMISSION INSTRUCTIONS DURING COVID

UPDATED AMENDMENT AND RESPONSE TO CONDITIONAL APPROVAL INSTRUCTIONS DURING COVID

Note: Please review the website regularly as we will be updating submission instructions as COVID restrictions are lifted.

COVID-19 Instructions required for Reopening

All research that currently includes “in person” visits with participants must seek the approval of the University of Manitoba COVID-19 Research Recovery Team (CRRT). This includes all clinical research including research that is piggy backing on to clinical care.

 

COVID-19 mitigation Strategies and RISK Statement

All new applications, amendments, annual approval requests or requests for reopening must include Standard Operating Procedures on mitigation strategies for the prevention of the spread of COVID-19 for in-person visits associated with the study. Participants attending in-person visits must also be provided with a COVID-19 Consent Appendix or have an appropriate COVID 19 Risk Statement added to the Consent Form. 


Annual and final reports are to be submitted as instructed on the Annual Study Status and Final Study Status reports.

OFFICE CLOSED TO FACE TO FACE INTERACTIONS
Please contact one of our staff via e-mail to assist you with any questions you may have:

Research Ethics Board Coordinator
Shelly.Rempel-Rossum@umanitoba.ca

BREB Questions contact:
Denise.cannon@umanitoba.ca 
Office Assistant
Working remotely

HREB Questions contact:
Beatrice.Kallu@umanitoba.ca 
Office Assistant
Working remotely